Head Marketing & Communications

London, UK (On-site)

£70K/yr – £90K/yrSenior Level5+ years expFull time

Posted 1 month ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the creation and scale of a new marketing and communications function; shape high-level narrative and evidence stories; build market position for a regulated clinical AI company; craft market-facing assets and an AI-driven MarComms operating system.

  • Growth/Ownership: Build and govern a full MarComms function across messaging, assets, PR, and enablement.
  • Narrative & Partnerships: Shape investor storytelling, journalist briefs, and pharma evidence partnerships with regulatory clarity.
  • Platform & Scale: Create an AI-enabled MarComms OS, workflows, and automation for repeatable, scalable campaigns.

Job Description

Responsibilities

  • Own marketing and communications end to end. Define how this function is built and then lead it.
  • Shape evidence narrative with Head of Evidence; brief journalists; work with CEO on investor story; shape narrative for pharma evidence partnership.
  • Own the narrative, messaging framework, and market position to make Sanome the reference clinical AI company.
  • Develop and ensure market-facing assets: product marketing and commercial enablement, brand and positioning, evidence and regulatory communications, PR and media, partner and channel marketing, conferences and events.
  • Build the Function with AI: use tools to create an AI-enabled MarComms operating system, workflows, and automation.
Sanome logo

Sanome

Sanome is closing the gap between data and decision in hospital care — building the AI-powered clinical intelligence layer that sits inside the hospital EPR and turns untapped patient data into real-time insight that clinicians can actually use, at the point of care, when it matters most.Today, 97% of hospital data goes unused. Clinicians are overstretched, operating at near-full bed capacity, spending precious time hunting for information across fragmented systems rather than caring for patients. Meanwhile, signals of deterioration — infections, sepsis, complications — are building quietly in the data, undetected until it's too late to act effectively or safely.Through deep integration with leading EPR providers and continuous data access across our hospital partners, Sanome is developing a pipeline of fully regulated, explainable AI-enabled clinical decision support tools, each certified as a Class IIb Software-as-a-Medical Device. Our proprietary SaMD Factory enables us to build, certify and deploy new clinical AI modules at a fraction of the time and cost of traditional development, underpinned by Sentinel — our real-time post-market evidence platform that continuously monitors clinical, operational and economic outcomes at every site.Embedded directly into clinical workflows and co-designed with frontline clinical teams, our tools give clinicians the right information at the right time — surfacing emerging risks hours to days before standard early warning systems, recommending next best actions aligned to local guidelines, and generating the real-world evidence needed to demonstrate impact at scale.

Founded in 2020
London, England, GBR
22 employees

Traffic Signals

Monthly Visitors
3.1K
Traffic Source Mix
Search
16.2%
Direct
69.1%
Referral
5.5%
Social
7.8%
Paid
1.3%

Headcount Trend

Current headcount: ~23

Funding

Last Raise
$2.7M
Pre Seed, 5 years ago

Funding History

  • Sep 2021
    Pre Seed • $2.7M